NCT05374538View on ClinicalTrials.gov

VIC-1911 Monotherapy in Combination With Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cancer

PHASE1TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

November 9, 2022

Primary Completion Date

August 26, 2023

Study Completion Date

August 26, 2023

Conditions
Non-small Cell Lung Cancer
Interventions
DRUG

VIC-1911

VIC-1911 tablets for oral administration

DRUG

sotorasib

Sotorasib tablets for oral administration

Trial Locations (5)

10016

New York University Langone Health Perlmutter Cancer Cancer, New York

21201

University of Maryland Cancer Center, Baltimore

30322

Emory University Winship Cancer Center, Atlanta

95817

University of California Davis, Sacramento

06473

Yale Cancer Center, North Haven

Sponsors

Collaborators (1)

Westat
All Listed Sponsors
collaborator

Westat

OTHER

lead

Vitrac Therapeutics, LLC

INDUSTRY